Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Acute Kidney Injury
9%
Adverse Event
13%
Adverse Outcome
11%
Apoplexy
32%
Area under the Curve
10%
Artificial Intelligence
12%
Atrial Fibrillation
11%
Biological Marker
18%
Biopsy Technique
10%
Bipolar Disorder
25%
Bleeding
13%
Body Mass Index
18%
Brain Ischemia
9%
Breast Cancer
26%
Cancer
21%
Cancer Cell
13%
Cardiovascular Disease
16%
Cardiovascular System
13%
Case-Control Study
16%
Chemoradiotherapy
9%
Chemotherapy
20%
Chronic Kidney Disease
24%
Cleft
8%
Cohort Analysis
49%
Colorectal Carcinoma
14%
Comorbidity
16%
Computer Assisted Tomography
20%
Congestive Heart Failure
11%
COVID-19
14%
Cross Sectional Study
13%
Diabetes
24%
Diabetes Mellitus
18%
Diseases
51%
End Stage Renal Disease
10%
Epidermal Growth Factor Receptor
10%
Hazard Ratio
30%
Health Care Cost
9%
Hemodialysis
10%
Hepatocellular Carcinoma
22%
Hyperoxia
9%
Hypertension
16%
Implant
13%
In Vitro
25%
Infection
17%
Inflammation
17%
Injection
14%
Knee
12%
Laparoscopic Surgery
12%
Logistic Regression Analysis
19%
Lung
20%
Lung Cancer
11%
Magnetic Resonance Imaging
27%
Malignant Neoplasm
30%
Maturity Onset Diabetes of the Young
16%
Mesenchymal Stem Cell
10%
Meta-Analysis
66%
Metastatic Carcinoma
10%
Morbidity
10%
Morphology
8%
Mortality Rate
8%
Myocardial Infarction
9%
Nasopharynx Carcinoma
8%
Neck
9%
Neoplasm
45%
Network Meta-Analysis
11%
Non Small Cell Lung Cancer
13%
Observational Study
11%
Obstructive Sleep Apnea
18%
Odds Ratio
47%
Oral
16%
Orthodontics
8%
Outpatient
8%
Overall Survival
18%
Pediatrics
16%
Pelvis
11%
Periodontitis
8%
Platelet
8%
Pneumonia
12%
Postoperative Complication
8%
Pregnant Woman
8%
Prevalence
24%
Prognostic Factor
10%
Programmed Cell Death
11%
Proportional Hazards Model
13%
Quality of Life
14%
Radiation Therapy
27%
Randomized Controlled Trial
36%
Rectum Cancer
13%
Recurrent Disease
18%
Retrospective Cohort Study
27%
Retrospective Study
15%
Schizophrenia
10%
Signal Transduction
8%
Surgeon
12%
Surgical Technique
9%
Survival Rate
11%
Systematic Review
57%
Transitional Cell Carcinoma
8%
Tumor
20%
Uterine Fibroid
8%
Pharmacology, Toxicology and Pharmaceutical Science
Adenosine Triphosphate
9%
Adverse Event
17%
All Cause Mortality
10%
Alternative Complement Pathway C3 C5 Convertase
11%
Angiotensin II
8%
Anti-Inflammatory Drug
24%
Antiinfective Agent
10%
Antioxidant
21%
Antiplatelet
9%
Atrial Fibrillation
11%
Biological Marker
13%
Brain Ischemia
12%
Breast Cancer
25%
Cancer Growth
11%
Carcinogenesis
12%
Cardiovascular Disease
20%
Case-Control Study
8%
Caspase 3
12%
Cell Viability
14%
Cerebrovascular Accident
29%
Chemotherapy Regimens
19%
Cholesterol
9%
Chronic Kidney Failure
30%
Chronic Obstructive Lung Disease
12%
Cisplatin
13%
Clinical Trial
9%
Cohort Study
65%
Colon Carcinoma
14%
Colorectal Carcinoma
22%
Comorbidity
9%
Congestive Heart Failure
15%
Cyclooxygenase 2
11%
Cytokine
17%
Cytotoxicity
25%
Diabetes Mellitus
19%
Diseases
37%
Doxorubicin
9%
End Stage Renal Disease
11%
Epidermal Growth Factor Receptor
22%
Ethanol
9%
Fibrosis
8%
Glioblastoma
10%
Glucose
16%
Heart Infarction
9%
Heme Oxygenase 1
8%
Hemodialysis
16%
Hypertension
16%
IC50
12%
Inducible Nitric Oxide Synthase
9%
Infection
16%
Inflammation
39%
Influenza
8%
Interleukin 1
11%
Interleukin 6
10%
Leporidae
12%
Lipid
19%
Lipopolysaccharide
20%
Liver Cell Carcinoma
27%
Lung Adenocarcinoma
8%
Lung Cancer
19%
Malignant Neoplasm
71%
Maturity Onset Diabetes of the Young
11%
Messenger RNA
18%
microRNA
8%
Mitogen Activated Protein Kinase
18%
Mitogen Activated Protein Kinase 3
8%
Mouse Model
10%
Nanoparticle
12%
Neoplasm
34%
Nicotine
10%
Nitric Oxide
17%
Non Small Cell Lung Cancer
20%
Nuclear Factor
14%
Osteoarthritis
15%
Parkinson's Disease
9%
Pathogenesis
9%
Pharmacokinetics
12%
Phosphotransferase
14%
Placebo
11%
Pneumonia
9%
Polysaccharide
9%
Prevalence
16%
Prostate Cancer
13%
Protein Kinase B
29%
Protein Kinase C
10%
Protein P53
10%
Randomized Controlled Trial
24%
Rat
100%
Rat Model
14%
Reactive Oxygen Metabolite
24%
Receptor
15%
Recurrent Disease
10%
Side Effect
8%
Sleep Disordered Breathing
9%
Statin (Protein)
10%
Therapeutic Effect
8%
Traditional Chinese Medicine
9%
Tumor Growth
12%
Tumor Necrosis Factor
15%
Western Blot
20%
Nursing and Health Professions
Accident Prevention
9%
Acute Heart Infarction
5%
Acute Kidney Failure
5%
Adherence
6%
Adverse Event
5%
Adverse Outcome
7%
Area under the Curve
5%
Atrial Fibrillation
6%
Bipolar Disorder
5%
Blood Pressure
7%
Body Mass
13%
Brain Ischemia
6%
Breast Cancer
14%
Cardiovascular Disease
5%
Case-Control Study
15%
Cerebrovascular Accident
44%
Chemotherapy
12%
Chronic Kidney Failure
18%
Clinical Outcome
7%
Clinical Trial
7%
Cognitive Defect
6%
Cohort Analysis
35%
Comorbidity
14%
Confidence Interval
65%
Congestive Heart Failure
7%
COVID-19
14%
Cross-Sectional Study
20%
Decision-Making
5%
Delirium
7%
Diabetes Mellitus
10%
Diseases
22%
Economic and Social Development
26%
Education
15%
Efficacy
21%
Embase
5%
Emergency Ward
9%
Frailty
6%
Gender Difference
5%
Hazard Ratio
14%
Health Care
10%
Health Care Personnel
6%
Health Literacy
7%
Hemodialysis
12%
Hepatitis C
5%
Hypertension
10%
Infection
8%
Intensive Care Unit
11%
Liver Cell Carcinoma
5%
Logistic Regression Analysis
18%
Longitudinal Analysis
5%
Malignant Neoplasm
18%
Maturity Onset Diabetes of the Young
9%
Medline
8%
Meta Analysis
59%
Metabolic Syndrome X
6%
Morbidity
5%
Mortality Rate
7%
National Health Insurance
13%
Neoplasm
5%
Network Meta-Analysis
13%
Neural Network
5%
Nurse
16%
Nursing
5%
Odds Ratio
41%
Outpatient
9%
Pediatrics
7%
Perception Deafness
5%
Physical Activity
6%
Pilot Study
11%
Pneumonia
6%
Practice Guideline
7%
Prevalence
32%
Propensity Score
7%
Proportional Hazards Model
6%
Prospective Cohort Study
5%
Psychometry
9%
Quality of Life
25%
Radiotherapy
5%
Receiver Operating Characteristic
7%
Schizophrenia
7%
Self-Efficacy
5%
Sepsis
7%
Sleep Disorder
6%
Sleep Disordered Breathing
10%
Sleep Quality
11%
Spinal Cord Injury
5%
Supplementation
6%
Syndrome
6%
Systematic Review
49%
Teaching Hospital
6%
Traumatic Brain Injury
9%
Treatment Outcome
5%
University Hospital
12%
Youth
9%